Association ofhypercalcemia with SLE is very rare. Since initial report in 1991 only hand full cases have been described mainly in adult patients sporadically. Three pattern observed in this rare presentation. Commonly it is associated with serositis and lymphadenopathy or lymphedema known as hypercalcemia-lymphadenopathy SLE {HL-SLE) or hypercalcemia-lymphedema syndrome. Second group do not show this particular association. Concomitant primary hyperparathyroidism is responsible for third variety. This report describes a case ofhypercalcemia associated with SLE from Bangladesh.
INTRODUCTION
Systemic lupus erythematosus (SLE) is uncommon cause of hypercalcemia in practice. This rare clinical association in a SLE patient described here along with review of clinical features and management.
CASE REPORT
Patient was a 28 year old female from Rangamati district of Bangladesh. She was diagnosed of SLE with class II lupus nephropathy (WHO classification) and antiphospholipid antibody syndrome in 2001. Nephropathy was in remission since initial immunosuppressive treatment. She was irregularly treated and without follow up for last few years. Her last renal function report before current presentation was normal. On September 2013 she presented with exertional dyspnoea, fatigue and polyuria. Clinical examination was unremarkable except marked pallor of body and conjunctiva and a resting tachycardia and mild dehydration. There was no history of abnormal blood loss. Haemoglobin was 4.4 gm/dl, ESR 145 mm in 1" hour. WBC and platelet counts were normal. Serum creatinine was 2.5 mg/dl. Anti ds-DNA titer elevated and C3 was low. ECG showed sinus tachycardia. Electrolytes were normal but serum calcium was 12.4 mg/dl (8-10 mg/dl). Urine analysis, serum albumin, serum alkaline phosphatase, serum phosphate, chest x-ray and ultrasonogram of abdomen were normal. Parathyroid hormone (PTH) level was 60 pg/ml (10- 8 Possible secondary causes of hypercalcemia need exclusion as far as possible before attributing hypercalcemia to SLE. Because of paucity of cases no definite characterization of patients with these SLE variant are yet to be established firmly. All but one case were reported in adult population. 7 Majority patients were young female but also reported in late onset SLE cases.
' 4 Current patient from
Bangladesh also complies with this observation. Hypercalcemia was reported usually at the time of diagnosis of SLE in past cases, so rarely hypercalcemia can be sole presenting feature ofSLE. Current patient differs from all past reported cases in that hypercalcemia was detected 13 year after establishing SLE diagnosis. Along with hypercalcemia wide range of system involvement as seen in SLE may be present. Calcium level is usually mild but severe hypercalcemic crisis may occur. 4 In some cases diagnosis of SLE may not be obvious. Previous case reports shows in many cases extensive search for malignancy was carried out at first as little was known regarding this SLE variety. Some cases may require confirmation by prolong follow up. PTH level usually remain depressed in first two variant described. A low PTH suggests either peptide or PTH receptor A RARE CASE REPORT FROM BANGLADESH DewanG related antibody as underlying cause ofhypercalcemia.
'
8 PTH is elevated in SLE cases associated with primary hyperparathyroidism. Some relates parathyroid hormone related protein (PTHrP) as possible explanation of hypercalcemia. But PTHrP is more commonly seen in malignant conditions. First reported case had high serum PTHrP. 5 Nonmalignant lymphoid tissue in SLE may produce PTHrP. Immunochemistry detected PTHrP expression in lymph node biopsy. 9 But serum PTHrP has been found to be normal or even negative in one but all subsequent patients after the original reporting in 1991. 1 Other postulates role of cytokines or anti PTH receptor antibody (stimulatory), anti FGF23 antibody as underlying cause. 
